|
⚲
|
| Keyboard |
| Farrell Thomas J
✚
|
|
|---|---|
| CIK # | 0001626859 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001626859] | |
| 4 | [0001626859] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bellicum Pharmaceuticals Inc | |
| Farrell Thomas J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bellicum Pharmaceuticals Inc BLCM
Employee Stock Option (right to buy) · derivative
|
2017-01-03 | Grant | 48,375 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Restricted Stock Units · derivative
|
2017-01-03 | Grant | 26,875 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Employee Stock Option (right to buy) · derivative
|
2016-01-04 | Grant | 160,000 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2015-10-01 | Sell | 2,500 | $14.58 | 36,450 |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2015-09-01 | Sell | 2,500 | $16.78 | 41,950 |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2015-08-03 | Sell | 2,500 | $20.24 | 50,600 |
|
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
|
2015-02-24 | Grant | 160,000 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2014-12-23 | Conversion | 4,451 | ||
|
Bellicum Pharmaceuticals Inc BLCM
Series B Convertible Preferred Stock · derivative
|
2014-12-23 | Conversion | 21,622 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
|
2014-12-23 | Conversion | 7,568 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2014-12-23 | Other | 607 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2014-12-23 | Conversion | 12,718 |